In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
Market OverviewThe global Pharma Contract Commercialization Organization (CCO) market is steadily evolving and is projected ...
invoX Pharma Limited (“invoX”), a research-driven global biopharmaceutical company with an advancing pipeline of innovative products, and Insilico Medicine (“Insilico”), a leading and global clinical ...
What are the top ten companies that academics go to when taking a research position in the private sector? There are a lot to choose from. The world of commercial research and development (R&D) spans ...
Copenhagen, DK and Boston, MA, U.S. November 05, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of ...
Hosted on MSN
Govt floats EOI for doing major Research & Development in pharma medtech sector and drugs
New Delhi: The government has sought expressions of interest (EoI) for research & development (R&D) projects to develop novel technologies in medicine, including medical devices and drugs for ...
Purdue University and leading academic and research universities in Ireland continue to build upon existing partnerships to bolster additional collaborative research efforts and study abroad ...
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announced that it has been selected ...
Forbes contributors publish independent expert analyses and insights. Sai writes about healthcare, innovation and technology. The last two years have witnessed explosive growth in the implementation ...
INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal to ...
ROCKVILLE, Md. and SUZHOU, China, March 25, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results